A recent review shows that proteomics-driven multi-omics integration reveals tumor heterogeneity and functional regulatory ...

From CAR T-cell breakthroughs to multi-omics precision tools, cancer research is rapidly evolving toward biomarker-guided trial designs. These approaches aim to match patients with the therapies most ...

Colorectal cancer is among the most prevalent and lethal malignancies worldwide, with liver metastases occurring in nearly one-third of patients and accounting for a major share of cancer-related ...

The advent of single-cell omics technologies has revolutionized our understanding of the complex cellular landscape in cancer. Traditional bulk sequencing ...

Cancer doesn’t follow a linear path—it evolves, adapts, and forks. Even within a single tumor, individual cells behave differently. They mutate, diverge, and form heterogeneous clones that fuel ...

Omics framework of colorectal cancer liver metastasis. Genomic, epigenetic, transcriptomic, proteomic, metabolomic, and microbiomic analyses were performed on tissue from primary colorectal cancer ...

A research team led by Prof. GU Hongcang and ZHANG Fan from the Hefei Institutes of Physical Science, Chinese Academy of Sciences, has identified a novel long non-coding RNA (lncRNA)-driven regulatory ...

Recent studies have revealed intricate links between host-associated microbiomes and systemic health. While the gut microbiome has received major attention, ...